Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations

BACKGROUND: EGFR exon 20 insertions (EGFR ex20ins) constitute a heterogeneous subset of EGFR-activating alterations. However, the effectiveness of standard therapy in patients with EGFR ex20ins remains poor. METHODS: In our study, we retrospectively collected next-generation sequencing (NGS) data fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Chao, Xing, Ruyue, Li, Mengmeng, Feng, Junnan, Sun, Rui, Wei, Bing, Guo, Yongjun, Ma, Jie, Wang, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479138/
https://www.ncbi.nlm.nih.gov/pubmed/36119499
http://dx.doi.org/10.3389/fonc.2022.949304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479138/
https://www.ncbi.nlm.nih.gov/pubmed/36119499
http://dx.doi.org/10.3389/fonc.2022.949304

Ejemplares similares